India’s First Covid-19 Vaccine: Final-Stage trials of Covaxin Begin in Bhubaneswar
ICMR selected around 21 medical institutes across the country including Bhubaneswar’s IMS and SUM Hospital where the Covaxin’s third phase trial would be conducted. It is expected to cover around 28,500 subjects, aged 18 years and above, and will be conducted in 21 sites across ten states.